FibroGen
FGEN
FGEN
152 hedge funds and large institutions have $208M invested in FibroGen in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
39% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 49
85% less capital invested
Capital invested by funds: $1.42B → $208M (-$1.22B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
152
Holding in Top 10
–
Calls
$28.1M
Puts
$14.8M
Top Buyers
1 | +$7.59M | |
2 | +$5.52M | |
3 | +$5M | |
4 |
BlackRock
New York
|
+$4.5M |
5 |
Jane Street
New York
|
+$4.48M |
Top Sellers
1 | -$63.9M | |
2 | -$25.2M | |
3 | -$17.9M | |
4 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$15.9M |
5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$15.5M |